• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Ovarian Cancer Global Clinical Trials Review, H2, 2011 - Product Image

Ovarian Cancer Global Clinical Trials Review, H2, 2011

  • ID: 2012341
  • December 2011
  • Region: Global
  • 138 pages
  • GlobalData

Ovarian Cancer Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2011" provides data on the Ovarian Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ovarian Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ovarian Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five READ MORE >



List of Tables
List of Figures
Introduction
Ovarian Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Ovarian Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Ovarian Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sanofi
Clinical Trial Overview of Sanofi
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Morphotek, Inc.
Clinical Trial Overview of Morphotek, Inc.
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
Telik, Inc.
Clinical Trial Overview of Telik, Inc.
ARCAGY - GINECO
Clinical Trial Overview of ARCAGY - GINECO
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Fresenius Biotech GmbH
Clinical Trial Overview of Fresenius Biotech GmbH
EntreMed, Inc.
Clinical Trial Overview of EntreMed, Inc.
Marshall Edwards, Inc.
Clinical Trial Overview of Marshall Edwards, Inc.
Endocyte, Inc.
Clinical Trial Overview of Endocyte, Inc.
Unither Pharmaceuticals
Clinical Trial Overview of Unither Pharmaceuticals
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Gynecologic Oncology Group
Clinical Trial Overview of Gynecologic Oncology Group
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
New York University School of Medicine
Clinical Trial Overview of New York University School of Medicine
Duke University
Clinical Trial Overview of Duke University
Southwest Oncology Group
Clinical Trial Overview of Southwest Oncology Group
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Wake Forest University
Clinical Trial Overview of Wake Forest University
Princess Margaret Hospital
Clinical Trial Overview of Princess Margaret Hospital
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
North Eastern Germany Society of Gynaecologic Oncology
Clinical Trial Overview of North Eastern Germany Society of Gynaecologic Oncology
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Five Key Clinical Profiles
Appendix Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, G7 Countries, 2011-
Ovarian Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Ovarian Cancer Therapeutics Clinical Trials, E7 Countries, 2011-
Ovarian Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Ovarian Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2011-
Ovarian Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Ovarian Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Morphotek, Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Telik, Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCAGY - GINECO, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Biotech GmbH, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Marshall Edwards, Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endocyte, Inc., 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Unither Pharmaceuticals, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Eastern Germany Society of Gynaecologic Oncology, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2011-
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011-

List of Figures
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011-
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011-
Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Ovarian Cancer Therapeutics Clinical Trials, G7 Countries (%), 2011-
Ovarian Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Ovarian Cancer Therapeutics Clinical Trials, E7 Countries (%), 2011-
Ovarian Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos